Judge Approves $10.5 Million Settlement Of Biopharmaceutical Stock Drop Suit
SAN DIEGO — A federal judge in California granted final approval to a $10.5 million settlement in a case brought by shareholders against a biopharmaceutical company and certain executives alleging that...To view the full article, register now.
Already a subscriber? Click here to view full article